STAT1/IFIT2 signaling pathway is involved in PD-L1-mediated epithelial-to-mesenchymal transition in human esophageal cancer
Open Access
- 2 February 2022
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 24 (5) , 927-940
Abstract
Background: We have previously reported significant change of epithelial to mesenchymal transition (EMT) phenotype of Eca-109 cells upon PD-L1 operation, and the cytoplasmic domain of PD-L1 played an essential role in promoting EMT of esophageal cancer cells. However, the underlying mechanism of how PD-L1 regulated EMT in esophageal cancer remained unclear. Methods: The overexpression and knockdown expression models of PD-L1 and IFIT2 were established by using lenti-virus transfection and RNAi method. Western blotting, qRT-PCR, CCK8 assay, transwell assay and wound healing assay were chosen to investigate their impact on the cells. The expression levels of IFIT2 and EMT markers in esophageal cancer tissues were examined by immunohistochemical staining. The rescue experiments were further applied to investigate the role of STAT1/IFIT2 signal pathway in the PD-L1-mediated EMT. Luciferase reporter assays were performed to examine the IFIT2 promoter activities upon knockdown expression of PD-L1 to identify the putative targeted region of IFIT2 promoter. Results: The STAT1/IFIT2 signal pathway was activated when PD-L1 was knockdown in human esophageal cancer cells. Decreased IFIT2 expression significantly increased the cellular abilities of viability, invasion and migration by using RNAi method in human esophageal cancer cells. Decreased IFIT2 expression in esophageal cancer tissues significantly correlated with EMT status, and could be used as an independent prognostic predictor for the patients. Rescue experiments in PD-L1 knockdown cells further confirmed that STAT1/IFIT2 pathway was involved in the PD-L1 mediated EMT of esophageal cancer cells. Moreover, the luciferase reporter assay also confirmed that in esophageal cancer cells, the promoter region of IFIT2 (-3K~-1K) remains more active in PD-L1 knockdown expression cells compared with controls. Conclusion: Our present work reveals a novel mechanism of how PD-L1 regulates EMT of cancer cells, namely STAT1/IFIT2 signal pathway is required in PD-L1 mediated EMT in human esophageal cancer.Keywords
Funding Information
- Changzhou Sci&Tech Program (CJ20210089)
- the National key R&D program (2018YFC1313400)
- The National Natural Science Foundation of China (31729001, 31800745, 81972869)
- the key r&d project of science and technology department of jiangsu province (BE2016660, BE2018645)
- changzhou high-level medical talents training projectute of technology (No. 2016CZBJ001)
- high-level talents project of jiangsu commission of health (LGY2020034)
- the applied basic research program of changzhou science and technology project (CJ20180061)
This publication has 30 references indexed in Scilit:
- Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cellsMolecular Cancer, 2015
- PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinomaMedical Oncology, 2015
- Interferon Induced IFIT Family Genes in Host Antiviral DefenseInternational Journal of Biological Sciences, 2013
- Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cellsOncogene, 2012
- Crystal structure of IFIT2 (ISG54) predicts functional properties of IFITsCell Research, 2012
- Immunoregulatory Molecule B7-H1 (CD274) Contributes to Skin CarcinogenesisCancer Research, 2011
- The Interferon Stimulated Gene 54 Promotes ApoptosisJournal of Biological Chemistry, 2011
- The ISG56/IFIT1 Gene FamilyJournal of Interferon & Cytokine Research, 2011
- IFN-Induced Protein with Tetratricopeptide Repeats 2 Inhibits Migration Activity and Increases Survival of Oral Squamous Cell CarcinomaMolecular Cancer Research, 2008
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cellsBlood, 2008